HealthTree
Foundation
Donate
Log In
Discover more
Video
BETA - How is GPRC5D being targeted in myeloma?
Posted by
HealthTree
• June 9, 2026
Description
BETA - How is GPRC5D being targeted in myeloma?
On this video
Ajai Chari, MD
Related Content
Video
Arlo-Cel - GPRC5D CAR-T: High Response Rates in Heavily Pretreated Myeloma | Susan Bal, MD
Video
New Talquetamab Combos Show Promise for Longer-Lasting Myeloma Control | Jeffrey Matous, MD
Video
Long-Term Success with Talquetamab Combo Therapy | Hang Quach, MD
Video
Update on Arlo-Cel, a GPRC5D CAR-T, in RRMM | Ciara Freeman, MD, PhD